About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

How early screening for type 1 diabetes and follow up monitoring can help you plan for the future

By: Brandpoint

(BPT) - Sponsored by Sanofi

Life often brings surprises, and many can be welcome. However, sometimes being caught off guard can be scary or overwhelming. This is especially true when it comes to your health, for example receiving an unexpected diagnosis like that of type 1 diabetes.

People often find out they have type 1 diabetes when they are in a later stage (stage 3) of the disease, which is when clinical symptoms begin to occur. In stage three, the body is no longer able to make enough or any insulin which causes blood sugar levels to rise much higher than the normal range. What happens next is lifelong dependence on insulin injections to maintain target blood sugar levels - and it may carry a heavy burden for individuals and their families alike.

Karim Jones and her family know this feeling all too well. Unknowingly, Jones' daughter was experiencing tell-tale symptoms of type 1 diabetes, including extreme thirst, unexplained weight loss, and fatigue. When they went to the doctor, Jones remembered a previous conversation she had with a friend and asked the doctor to test her daughter for type 1 diabetes. It turned out her daughter not only had type 1 diabetes, but she was also in diabetic ketoacidosis (DKA), a life-threatening complication of type 1 diabetes.

Jones immediately received a deluge of information about managing her daughter's blood sugar levels, the impact of diet, insulin dosing, and more, which made her feel overwhelmed and uncertain. When the stakes are as high as supporting a child's health, more time to learn how to manage the disease can be extremely valuable. Early detection of type 1 diabetes is possible through screening and this advanced information can provide time to prepare for the future - but early screening for type 1 diabetes is relatively uncommon prior to diagnosis due largely to a lack of awareness. The1Pledge.com has more information on why early screening can be important.

'Knowing in advance, even by just one month, would have made an important difference for our entire family and given us the time to prepare in a way that wasn't so rushed,' Jones shares. 'Type 1 diabetes management requires countless extra decisions each day that I'm responsible for as a caregiver. It's on me to manage my daughter's health, and the mental load that goes along with that responsibility is one of the hardest parts.'

Indeed, advanced notice through a blood test that can detect type 1 diabetes-related autoantibodies early can help families in a multitude of ways, including but not limited to:

  • Building a multidisciplinary care team of doctors, nurses, nutritionists, and other supportive healthcare providers to meet with (typically every 3-6 months).
  • Learning more about the disease from that care team to better recognize symptoms when they do arise (stage 3) and potentially reducing the risk of going through DKA by up to 50%.
  • Developing the skills needed to manage the disease, in the face of up to 10 finger pricks per day to measure blood sugar and an estimated 1,460 insulin injections each year.

'My husband and I agreed that we never wanted to be caught off guard like that again, so after my daughter was diagnosed, our whole family got screened, including our other three children,' Jones notes. 'As a parent, you would do anything for your kids, and when I learned screening was an option after my daughter's diagnosis, I wasn't going to miss out on an opportunity to know if my family was at risk. Before we got the family screened, I felt like I was living in fear, worried that if my child was thirsty, it might be a red flag; now that we've gotten the kids screened, I feel better informed.'

Jones continued: 'As a mother who has lived through an unexpected diagnosis, I believe everyone should get screened. About 90% of people diagnosed with type 1 diabetes do not have a family history of the disease, which was the case for my daughter. If it's fear of knowing that's stopping you from getting screened, hear me when I say that you don't want to get to a point where your child is experiencing DKA - that is much, much scarier. Knowing in advance may make a difference for your family.'

Talk to your doctor about screening for type 1 diabetes.

Sanofi does not provide medical advice, diagnosis, or treatment - information is provided for educational purposes only. Your doctor is the best source of health information. Talk to your doctor if you have any questions about your health or treatment.

Karim Jones is a paid spokesperson for Sanofi.

More News

View More
3 Heavily Shorted Stocks That Could Pop on Rate Cuts
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers ETSY SMR SOUN
Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
Via MarketBeat
Tickers AVGO META
PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Via MarketBeat
Tickers PEP
Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been
Via MarketBeat
Tickers DKNG
Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom
Via MarketBeat
Tickers BUD STZ
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.